Featured Posts
Blog
Fauci’s lasting legacy will be the damage he did to science and government
Anthony Fauci isn’t faring well in the court of public opinion. His recently divulged “diary” and subsequent July 29 appearance before the Senate Homeland…
News Release
FDA commissioner resignation opens opportunity for refocus on science over politics
After a somewhat tumultuous tenure, FDA commissioner Marty Makary is stepping down. While Dr. Makary made his mission to accelerate drug approval and bring…
Blog
Don’t hinder biosimilar development
In its most recent legislative session, the Florida legislature considered precluding pharmacy benefit managers (PBMs) from holding an investment interest in biosimilar manufacturing.
Search Posts
Newsletter
Bailout Fallout, the New (Green) Deal and Scaring Parents with Toxic Arguments
The House and Senate agree on a $700 billion financial bailout bill. Environmentalists try to leverage the mortgage and Wall Street financial crisis to argue…
Citation
the presidential candidates’ views on the biotech industry
Citation
FDA approval for “biogeneric” drugs
Newsletter
Hurricane Recovery, Union Politics and Disaster Insurance
Residents of the hurricane-ravaged Gulf Coast are being advised to avoid taps and drink only bottled water. Unions increase their spending on campaign advertisements and…
Op-Eds
Activists Hit the (Plastic) Bottle Again
Anti-chemical activists opened a new front in their jihad against the plastics chemical bisphenol-A (BPA) this week.
Op-Eds
CAFE Oh Nay, Standard Has Hurt
The Detroit auto industry is clearly a victim of CAFE. But it’s not the only victim, and it’s not even the most prominent one.